AA
GHDX

ALPS Advisors’s Genomic Health, Inc. GHDX Stock Holding History

ALPS Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,114
Closed -$347K – 880
2019
Q3 		$347K Buy
+5,114
New +$351K ﹤0.01% 771

ALPS Advisors's GHDX Position: Q4 2019 in Review

ALPS Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 5,114 shares — an estimated $347K sold.

ALPS Advisors first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $347K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • ALPS Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • ALPS Advisors sold 5,114 Genomic Health, Inc. shares in Q4 2019, an estimated $347K.
  • ALPS Advisors first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
  • ALPS Advisors's Genomic Health, Inc. position peaked at $347K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on ALPS Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.